The largest database of trusted experimental protocols

Thrombinoscope

Manufactured by Diagnostica Stago
Sourced in France

The Thrombinoscope is a laboratory instrument designed to measure the generation of thrombin, a key enzyme involved in the blood coagulation process. The device provides quantitative information about the kinetics of thrombin generation, which can be useful in assessing various hemostatic disorders and monitoring anticoagulant therapies.

Automatically generated - may contain errors

7 protocols using thrombinoscope

1

Thrombin Generation Measurement in PPP

Check if the same lab product or an alternative is used in the 5 most similar protocols
Thrombin generation was measured in platelet-poor plasma (PPP), which was obtained by centrifugation at 2000× g for 20 min. Thrombin generation measurement was performed using a semi-automated calibrated automated thrombogram (CAT; Thrombinoscope, Diagnostica Stago, Asnières, France). The measured parameters were lag time (LAG), time to peak (TTP), peak height (PEAK), and endogen thrombin potential (ETP).
+ Open protocol
+ Expand
2

Calibrated Thrombin Generation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Calibrated automated thrombin generation was performed as described by Hemker.34 (link) Briefly, a 96-well microplate format and the calibrated automated thrombin generation assay (Thrombinoscope, Diagnostica Stago) were used to measure thrombin generation in plasma based on thrombin’s hydrolysis of a fluorogenic substrate (Z-GLY-GLY-Arg-AMC). All samples were run in duplicate and in parallel with calibrator wells.
The following parameters were measured: lag time (LT; min) = time needed for initial thrombin generation, (i.e., 10 nM); peak thrombin generation (nM), endogenous thrombin potential (ETP; nM* min) = amount of thrombin that can be generated after in vitro activation of coagulation; and time to thrombin peak (TTP, min).
+ Open protocol
+ Expand
3

Biocompatibility and Neutralization Activity of polyP Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two sets of experiments were carried out to determine the biocompatibility of the polyP inhibitors and their polyP neutralization activities, respectively. In the first set of experiments, only polyP inhibitors were used (for determining biocompatibility) without adding polyP, and in the second set of experiments, both polyP inhibitors and different molecular weight polyPs (SC polyP and LC polyP) were used to evaluate neutralization activity of the inhibitors.
Thrombin generation assays were carried out at 37 °C by measuring the fluorescence intensity upon cleavage of a fluorogenic substrate, Z-Gly-Gly-Arg-AMC by the generated thrombin, using the supplied “FluCa” and “PPP-low” reagents on the Thrombinoscope (Diagnostica Stago) system. PNP (20 donors) from George Kind Bio-Medical was mixed 1:1 with HBS (20 mM HEPES with 100 mM NaCl at pH 7.4). Phosphatidylcholine/phosphatidylserine (80:20) (PCPS) liposomes were added to obtain a final concentration of 25 μM. Reaction wells contained 80 μL of the 50% plasma and 20 μL of the supplied substrate/calcium reagent. Serial dilutions of inhibitors were prepared in 50% plasma:HBS immediately before each experiment, and two technical replicates were carried out each time.
The fluorescence intensity was recorded at 37 °C every 30 s over a period of 1.5 h and converted to thrombin concentration using the supplied calibrator and software.
+ Open protocol
+ Expand
4

Thrombin Generation Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
PPP samples were handled and treated as described in the CAT-I method above. Calibration was performed in the buffer system by measuring the fluorescence derived from a known concentration of thrombin and fluorogenic substrate (AMC) in buffer. This calibration was performed only once. Samples were divided into two subsamples, the first subsample (80 μL) was supplemented with 20 μL of AMC and the second subsample (80 μL) was added to 20 μL of trigger-reagent containing TF and PL (STG-Thromboscreen). The measurement was initiated by addition of 20 μL fluorogenic substrate (Z-Gly-Gly-Arg-AMC) plus calcium chloride (FluCa). Thrombin generation was assessed at 37 °C by measuring the signal of the cleaved AMC using a Fluoroskan Acsent (Thermofisher) plate reader with the wavelengths set to 390 (excitation)- 460 nm (emission) in a 96-well plate. All samples were measured in quadruplicates. The thrombin measured over time was calculated with a modified Thrombinoscope (Diagnostica Stago, Asnières-sur-Seine, France) taking into account the modified calibration. Thrombin generation parameters obtained are the same as listed with CAT-I method.
+ Open protocol
+ Expand
5

Coagulation Assays for Thrombosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sodium citrate (11 mmol/L final) blood samples were centrifuged at 2500g at 4°C for 15 min to generate plasma. Both aPTT and PT were determined by standard methods using TriniCLOT aPTT S (Tcoag, Bray, Ireland) and TriniCLOT PT Excel (Tcoag) on a KC4 Delta coagulation analyzer (Tcoag) (Metzger et al. 2015). Ellagic acid was used as a trigger for aPTT, while 100 μL tissue factor (TF) + CaCl2 mix was used to trigger measure of PT. Thrombinoscope (Diagnostica Stago, Parsippany, NJ, USA) was according to the manufacturer's instructions. Plasma (60 μL) was incubated with 15 μL recombinant human fXIa (rhfXIa, 1, 3, 10 pmol/L) or TF (1, 5, 20 pmol/L, Diagnostica Stago, Parsippany, NJ, USA) at 37°C for 5 min. This was followed by automatic injection of 15 μL of FluCa buffer to initiate fIIa. Peak thrombin generation was recorded.
+ Open protocol
+ Expand
6

Quantifying Thrombin Generation in Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Thrombin generation in patient samples was quantified using the calibrated automated thrombogram (Thrombinoscope, Diagnostica Stago) method.10 (link) Plasma (80 μL) was dispensed in triplicate into round 96-well plates (Immulon 2HB, Dynex) and the plate warmed to 37 °C for 5 minutes before addition of the starting reagent (20 μL/well) containing PPP low reagent (Diagnostica Stago), 2.5 mmol/L fluorogenic substrate (Z-Gly-Gly-Arg-AMC.HCl) and 16.6 mmol/L CalCl2. Measurements were taken every minute for 1 hour in a Fluoroscan Ascent fluorometer (Thermo Labsystems, Thermo Fisher Scientific). Data were analyzed using the Thrombinoscope software (Synpase Bv) producing standard parameters including lag time, velocity index, peak thrombin generation, and endogenous thrombin potential.
+ Open protocol
+ Expand
7

Thrombin Generation Assay for HES Impact

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the impact of HES on coagulation, thrombin generation was measured in same COVID-19 patients (n = 10) in the presence of either HES or saline. Briefly, 80 μL of platelet-poor plasma was dispensed into the round-bottom wells of 96-well microtitre plates (Greiner). A total of 20 μL of a mixture containing tissue factor and phospholipids (PPP reagent, Stago) was added to the plasma sample. Another 20 μL of Heptem reagent (Tem Innovation) containing heparinase was added to each well to neutralize the heparin in the patient’s plasma. Then, 36 μL of HES or saline was added, and the starting reagent (20 μL per well) contained fluorogenic substrate and CaCl2. Thrombin generation was measured in a Fluoroscan Ascent fluorometer (Thermolabsystems) using the calibrated automated thrombin generation assay (TGA), and a dedicated software program, Thrombinoscope (Diagnostica Stago), enabled the calculation of thrombin activity and displayed thrombin activity with time. All experiments were carried out in duplicate. Endogenous thrombin potential (area under the thrombin generation curve), peak thrombin height, and time to peak were analyzed.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!